Additionally, these medications slow gastric emptying, which prolongs the sensation of fullness after meals and reduces appetite through central nervous system effects on satiety centers in the hypothalamus
In addition to glycemic control, the market is increasingly being shaped by demand for obesity management and cardiometabolic risk reduction
Either option works
The compound reaches peak blood levels within 1-3 hours of sublingual administration, which means the strongest appetite control kicks in right around lunchtime, precisely when food decisions tend to get difficult for most people managing their diet on GLP-1 medications
Please support CSPI today, and consider contributing monthly
Nauck MA, Kleine N, rskov C, Holst JJ, Willms B, Creutzfeldt W